The travel industry anticipates a shift as appetite suppressant tools, such as Ozempic, become prevalent. Airlines, all-inclusive resorts, cruises, experience providers, and tour operators are positioned to benefit from a leaner clientele. Meanwhile, theme parks, hotels, and entertainment venues relying on food and beverage revenue may face challenges.
You will be redirected in 2 seconds.
CLICK HERE FOR FULL STORY